Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, Tang Y, Qin Q, Wang F, Qiao Y, Shi S, Wang YJ, Du Y, Zhang J, Zhang J, Luo B, Qu Q, Zhou C, Gauthier S, Jia J. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19(1):81–92.

Article  PubMed  Google Scholar 

Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, Ceravolo R, Siciliano G, Bonuccelli U, Elahi FM, Vergallo A, Lista S, Giorgi FS, Hampel H. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn. 2020;20(4):421–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O’Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Alzheimer’s Dementia J Alzheimer’s Assoc. 2016;12(3):292–323.

Article  Google Scholar 

Lashley T, Schott JM, Weston P, Murray CE, Wellington H, Keshavan A, Foti SC, Foiani M, Toombs J, Rohrer JD, Heslegrave A, Zetterberg H. Molecular biomarkers of Alzheimer’s disease: progress and prospects. Dis Models Mech. 2018;11(5):dmm031781.

Article  Google Scholar 

Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol. 2013;126(3):365–84.

Article  CAS  PubMed  Google Scholar 

Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J Neuropathol Exp Neurol. 2012;71(4):266–73.

Article  PubMed  Google Scholar 

Moussaud S, Jones DR, Moussaud-Lamodière EL, Delenclos M, Ross OA, McLean PJ. Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegen. 2014;9:43.

Article  Google Scholar 

Atri A. The Alzheimer’s disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019;103(2):263–93.

Article  PubMed  Google Scholar 

Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson’s disease. Revue Neurol. 2016;172(1):14–26.

Article  CAS  Google Scholar 

Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197–211.

Article  PubMed  Google Scholar 

Gustavsson T, Syvänen S, O’Callaghan P, Sehlin D. SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer’s disease. Transl Neurodegen. 2020;9(1):37.

Article  CAS  Google Scholar 

Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson’s disease. Parkinsonism Related Disord. 2010;16(2):79–84.

Article  Google Scholar 

Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain J Neurol. 1991;114(Pt 5):2283–301.

Article  Google Scholar 

Kovács T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer’s disease: olfactory bulb is involved in early Braak’s stages. NeuroReport. 2001;12(2):285–8.

Article  PubMed  Google Scholar 

Wu N, Rao X, Gao Y, Wang J, Xu F. Amyloid-β deposition and olfactory dysfunction in an Alzheimer’s disease model. J Alzheimer’s Dis JAD. 2013;37(4):699–712.

Article  CAS  PubMed  Google Scholar 

Dintica CS, Marseglia A, Rizzuto D, Wang R, Seubert J, Arfanakis K, Bennett DA, Xu W. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology. 2019;92(7):e700–9.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki H, Sugiura S, Nakashima T, Teranishi M, Shimono M, Murotani K, Sakurai T, Uchida Y, Saji N. Cognitive impairment is correlated with olfactory identification deficits in older Japanese adults: a cross-sectional study using objective and subjective olfactory measures. Geriatr Gerontol Int. 2022;22(11):924–9.

Article  PubMed  Google Scholar 

Iannilli E, Stephan L, Hummel T, Reichmann H, Haehner A. Olfactory impairment in Parkinson’s disease is a consequence of central nervous system decline. J Neurol. 2017;264(6):1236–46.

Article  PubMed  Google Scholar 

Rey NL, Wesson DW, Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis. 2018;109(Pt B):226–48.

Article  CAS  PubMed  Google Scholar 

Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA. 2004;101(13):4637–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Liang M, Wang L, Tian L, Zhang X, Li K, Jiang T. Altered functional connectivity in early Alzheimer’s disease: a resting-state fMRI study. Hum Brain Map. 2007;28(10):967–78.

Article  Google Scholar 

Song Y, Wu H, Chen S, Ge H, Yan Z, Xue C, Qi W, Yuan Q, Liang X, Lin X, Chen J. Differential abnormality in functional connectivity density in preclinical and early-stage Alzheimer’s disease. Front Aging Neurosci. 2022;14: 879836.

Article  PubMed  PubMed Central  Google Scholar 

Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S. Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci. 2012;323(1–2):16–24.

Article  PubMed  Google Scholar 

Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF. Olfactory impairment predicts cognitive decline in early Parkinson’s disease. Parkinsonism Related Disord. 2016;25:45–51.

Article  Google Scholar 

Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW. Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun. 2012;3:1009.

Article  PubMed  Google Scholar 

Benseny-Cases N, Álvarez-Marimon E, Aso E, Carmona M, Klementieva O, Appelhans D, Ferrer I, Cladera J. In situ identification and G4-PPI-His-Mal-dendrimer-induced reduction of early-stage amyloid aggregates in Alzheimer’s disease transgenic mice using synchrotron-based infrared imaging. Sci Rep. 2021;11(1):18368.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He F, Qi G, Zhang Q, Cai H, Li T, Li M, Zhang Q, Chen J, Ming J, Tian B, Zhang P. Quantitative phosphoproteomic analysis in alpha-synuclein transgenic mice reveals the involvement of aberrant p25/Cdk5 signaling in early-stage Parkinson’s disease. Cell Mol Neurobiol. 2020;40(6):897–909.

Article  CAS  PubMed  Google Scholar 

Takahashi K, Ohsawa I, Shirasawa T, Takahashi M. Early-onset motor impairment and increased accumulation of phosphorylated alpha-synuclein in the motor cortex of normal aging mice are ameliorated by coenzyme Q. Exp Gerontol. 2016;81:65–75.

Article  CAS  PubMed  Google Scholar 

Toft-Bertelsen TL, Ziomkiewicz I, Houy S, Pinheiro PS, Sørensen JB. Regulation of Ca2+ channels by SNAP-25 via recruitment of syntaxin-1 from plasma membrane clusters. Mol Biol Cell. 2016;27(21):3329–41.

Article  PubMed  PubMed Central  Google Scholar 

Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease. Alzheimer’s Res Ther. 2020;12(1):21.

Article  Google Scholar 

Lista S, Hampel H. Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease. Expert Rev Neurother. 2017;17(1):47–57.

Article  CAS  PubMed  Google Scholar 

Guerini FR, Farina E, Costa AS, Baglio F, Saibene FL, Margaritella N, Calabrese E, Zanzottera M, Bolognesi E, Nemni R, Clerici M. ApoE and SNAP-25 polymorphisms predict the outcome of multidimensional stimulation therapy rehabilitation in Alzheimer’s disease. Neurorehabil Neural Repair. 2016;30(9):883–93.

Article  PubMed  Google Scholar 

Agliardi C, Guerini FR, Zanzottera M, Riboldazzi G, Zangaglia R, Sturchio A, Casali C, Di Lorenzo C, Minafra B, Nemni R, Clerici M. SNAP25 gene polymorphisms protect against Parkinson’s disease and modulate disease severity in patients. Mol Neurobiol. 2019;56(6):4455–63.

Article  CAS  PubMed  Google Scholar 

Hoerder-Suabedissen A, Korrell KV, Hayashi S, Jeans A, Ramirez DMO, Grant E, Christian HC, Kavalali ET, Wilson MC, Molnár Z. Cell-specific loss of SNAP25 from cortical projection neurons allows normal development but causes subsequent neurodegeneration. Cereb Cortex (New York NY: 1991). 2019;29(5):2148–59.

Google Scholar 

Halbgebauer S, Steinacker P, Hengge S, Oeckl P, Abu Rumeileh S, Anderl-Straub S, Lombardi J, Von Arnim CAF, Giese A, Ludolph AC, Otto M. CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2022;93:1059–65.

Article  Google Scholar 

Kivisäkk P, Carlyle BC, Sweeney T, Quinn JP, Ramirez CE, Trombetta BA, Mendes M, Brock M, Rubel C, Czerkowicz J, Graham D, Arnold SE. Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease. Alzheimer’s Res Ther. 2022;14(1):58.

Article  Google Scholar 

Park H, Kim H, Kim S, Cha H. The association between olfactory function and cognitive impairment in older persons with cognitive impairments: a cross-sectional study. Healthcare (Basel, Switzerland). 2021;9(4):399.

PubMed  Google Scholar 

Öhrfelt A, Brinkmalm A, Dumurgier J, Zetterberg H, Bouaziz-Amar E, Hugon J, Paquet C, Ble